Growth Reaccelerated, but Margins Are in Inflation's Grip
Revenue hit 15.1% YoY—proving the company's growth step-up is real. Yet gross margins collapsed 138 basis points as commodity costs surged, leaving Q3 margin recovery entirely dependent on whether mid-November price increases actually stick with consumers.
₹888.5 Cr
+15.1% YoY | +26.9% QoQ
₹74.1 Cr
+17.8% YoY | NPM 8.3%
12.9%
defended despite gross margin compression
55.1%
−138 bps YoY to commodity inflation
Eureka Forbes delivered exactly what management promised on the prior call: a step-up in revenue growth from 12.7% to 15.1% YoY, broad-based across water purifiers, robotics, and emerging categories, with profitability intact at 8.3% net margin. But the quarter reveals a company under siege by commodity inflation. Gross margins fell 138 basis points to 55.1%, and management deliberately delayed price increases through the festive season to protect growth momentum. The result: flat H1 margins and a Q3 margin recovery now entirely contingent on whether 3–4% price increases stick post-Diwali. This is no longer a question of whether Eureka can grow; it's whether it can defend margin recovery while holding volume.
The core tension: growth vs. pricing power
The P&L tells a story of two competing forces. On one side, H1 revenue grew to ₹1,590 Cr, up 15.1% YoY from ₹1,381 Cr, confirming that the company's momentum is real and broad-based. Water purifiers alone grew over 30% sequentially, and emerging categories (robotics, water softeners, air purifiers) are accelerating at 2x the company average. On the other, gross margins shrank 138 bps to 55.1% as steel, motors, and materials costs surged with no abatement in sight. Management responded by taking cost out elsewhere: opex ratio fell 181 bps to 41.6% of revenue, enabling operating profit margin to hold at 12.9% and net margin to expand to 8.3% despite the gross margin collapse.
The gamble: by holding prices flat through Diwali, management bought growth and market share. Now it must prove that 3–4% price increases are both achievable without demand destruction (the bear case) and sufficient to recover margins (the bull case). The call offered no new demand elasticity data, and management acknowledged Q3 will be "transitionary" before Q4 recovery. That's code for margin volatility is coming.
H1 FY27 revenue growth of 15.1% YoY (step-up from 12.7% prior year)
Delivered ₹1,590 Cr H1 revenue (15.1% YoY growth confirmed)
Supported
FY27 full-year EBITDA margins expected flat vs. FY26 (no expansion)
H1 margins flat at 12.2% YoY; on track if Q4 recovery hits target
Supported H1, Q3 at risk
Water Purifier sequential growth over 30% QoQ
Overall Q2 revenue +26.9% QoQ; water purifier cited as high-growth driver
Corroborated
Emerging categories growing 2x+ company average
Management detailed robotics, water softeners, air purifiers all accelerating
Plausible
PAT of ₹74.1 Cr (highest-ever quarterly)
Delivered ₹74.1 Cr PAT, +17.8% YoY
Supported
What changed on this call
Growth trajectory confirmed and accelerating (15.1% vs 12.7% prior year)
Margin guidance reaffirmed but phased: Q3 transitional, Q4 recovery expected
Emerging categories explicitly 2x growth; robotics ₹1,000 Cr FY30 target reaffirmed
New product innovation detailed (2-year, 4-year filter products; Aerogard air purifier launch with 6 SKUs)
Bull case vs. bear case
How the street is positioned
The stock trades at ₹365 (as of 2026-11-06), down 45.4% from its all-time high of ₹668.3 and below its 50-day and 200-day moving averages (₹367.4 and ₹448 respectively). This isn't a stock the market has gotten excited about post-result—it's a stock in a medium-term drawdown, albeit above its 52-week low of ₹300.1. RSI sits at 58.9 (neutral).
Ownership flows are mixed: FII trimmed by 41 bps to 13.25% in Q1, suggesting foreign fund caution on near-term margin recovery execution. Domestic institutional investors added 55 bps to 6.70%, signaling local conviction on the long-term growth story despite near-term margin volatility. Promoter stake remains steady at 62.55%.
The drawdown context matters: a 45% fall from ATH can mean a stock that was overpriced or one in genuine crisis. For Eureka, the data suggests the former. The company is growing faster (15.1% vs 12.7%), margins are under pressure but not broken (8.3% NPM defended), and margins are set to recover if pricing sticks. The stock's decline reflects the market repricing for near-term margin volatility and waiting for proof of pricing power. Foreign investors are waiting; domestic investors are buying the dip.
Risks, ranked by how much they should concern a holder
Commodity inflation persists with no abatement
HighGross margins already down 138 bps; further inflation forces deeper price increases or margin surrender. Management offers no visibility on commodity trajectory.
Mid-November pricing increases don't stick (demand elasticity higher than expected)
HighQ3 margin recovery is entirely contingent on price increases being accepted. If elasticity is high or consumer resistance emerges, Q4 margin target is missed and full-year guidance is cut.
Water purifier competitive intensity accelerates with new entrants
MediumManagement noted rising competition; Eureka's premium positioning and innovation can defend share, but pricing power erodes if intensity accelerates faster than expected.
Emerging categories fail to deliver at scale
MediumRobotics, water softeners, and air purifiers are growing fast but still early-stage. Supply chain, product quality, and service delivery at higher volumes is unproven.
FII outflow accelerates if margin recovery misses
Low–MediumFII already trimmed 41 bps; if Q3/Q4 results disappoint on margins, foreign fund selling could drive stock lower, cascading other selling.
What to watch next
1 · Mid-November price increase execution and Q3 pre-result color
Did the 3–4% price increases actually go through? Is there early feedback on demand impact (retail, e-commerce, channel feedback)? This is the highest-priority signal. Delayed guidance raise or Q3 guidance cut would be red flags.
2 · Q3 FY27 results—margin trend
The real test. Is Q3 margin the transitionary dip management expects, or deeper? If operating margin declines more than 50–100 bps from Q2, pricing has failed. If it holds or improves, the bull case gains traction.
3 · Water purifier competitive dynamics and share data
Management claimed market leadership; new competition is confirmed. Next quarterly call should offer transparency on market share trends, ASP realization, and new competitor positioning. Loss of share to discounters would signal a pricing power problem.
The bottom line
This was a steady execution quarter—growth reaccelerated, profitability defended—not a step-change. The company proved it can grow in a tough inflationary environment. What it hasn't yet proven is that it can recover margins while holding volume.
Eureka's guidance track record is strong (Q1 call targets all confirmed), and management's tone was measured and honest about challenges. That credibility matters.
The number to track from here is gross margin in Q3 and Q4. If it recovers to 55.5%+ by Q4, the 45% stock drawdown was an opportunity. If it stays below 55%, the market was right to reprice.
Volume momentum & margin recovery on the watch for Q2
Eureka Forbes reports Q2 FY27 on November 2. The Street expects sustained revenue growth, but margin recovery from Q1's 10.5% EBITDA dip and execution on water purifier penetration (7% household adoption) will be the real test.
For Eureka Forbes, the earnings print will hinge on three threads: whether volume growth (the 15.3% YoY revenue jump in Q1) carries into Q2, whether EBITDA margins normalize back toward FY26's 12.2% after Q1's 10.5% dip, and whether the company is penetrating the water purifier opportunity (7% household adoption) at the cadence investors have priced in. Everything else—GST relief, ESG ratings, pledges—is noise if execution on these three stays on track.
What to expect: the on-plan grid
~₹700-750 Cr
Q1 was ₹700 Cr (+15.3% YoY); Q2 seasonal run-rate suggests mid-to-high end of range
~12%
Q1 slipped to 10.5% (vs FY26 FY 12.2%); street expects Q2 to normalize as spends stabilize
~₹45-50 Cr
Q1 PAT ₹57 Cr included ₹19.5 Cr gratuity one-off; Q2 likely normalized run-rate
~43%
Electric purifier segment was 42.8% of mix in FY26; on-plan for Q2
A strong print: Revenue ₹750+ Cr with EBITDA margin at or above 12%, signaling both volume momentum and margin discipline. Electric water purifier growth accelerating ahead of the 7% penetration floor, with commentary on emerging markets (small appliances, robotics) holding up. PAT normalized at ₹48-50 Cr. A weak print: Revenue flatlining near ₹680 Cr or lower (momentum stalls vs Q1). EBITDA margin stays below 11%, suggesting cost pressures or promotional intensity weighing harder. Water purifier mix declining as a % of overall revenue. Any fresh regulatory surprises.
On track for the year?
Eureka Forbes guided for meaningful acceleration from FY27 onwards, with revenue doubling to ₹5,400–5,600 Cr and EBITDA tripling to ₹800–850 Cr by FY30. Q1 delivered on the volume front (15.3% YoY), but Q1 margins disappointed (10.5% vs FY26's 12.2%). For the company to hit its mid-term targets, it needs to prove FY27 can grow top-line and recover operating leverage—not one or the other. Q2 is the first real test of that thesis. If margins stay compressed, the market will reprrice the FY30 feasibility, especially given the stock is already down 54% from its ₹668 high.
What the Street says
Since last quarter: the filings read
1 · GST liability relief: ₹273 Cr show cause → ₹4.5 Cr rectification order (Oct 1)
A major de-risking event. The Deputy Commissioner's GST notice for FY22-23 was significantly reversed on appeal. This removes a material contingency from the P&L and clears a regulatory overhang that had been weighing on sentiment.
2 · Promoter pledges 74% of stake (Sep, Aug) — liquidity signal?
Lunolux Midco (62.55% holder) disclosed pledging 62.55% + an additional 11.53% on Sep 22 and through Catalyst Trusteeship on Sep 18. The timing (post-ATH decline) and scale suggest either refinancing or covenant pressure, not conviction buying. Street will be watching for any margin calls or further encumbrances.
3 · ESG upgrade: CRISIL ESG score 58 → 62 (Sep 9)
Positive sentiment on sustainability; SES ESG also rated 63.4. Routine for a consumer-facing comapny, but supports long-term narrative on brand resilience and corporate governance.
4 · Institutional investor roadshow (Aug 24)
Pre-result engagement with FIIs/DIIs. FII ownership has drifted 0.41pp lower QoQ to 13.25%, and DII is steady at 6.70%; this suggests some FII caution but no panic exit.
The three things to watch on result day
1. Revenue growth acceleration or stall? Q1's 15.3% YoY was the highest ever per the disclosures. If Q2 slips to single digits (seasonal + market softness) or stays above 12% (momentum intact), that sets the tone for the full year. 2. Margin recovery to 12%+. Q1's 10.5% EBITDA margin was the real miss. Higher A&P spends and lower gross margin drove the slip. Management commentary on cost normalization and pricing power in water purifiers will be critical. 3. Water purifier mix and growth rate. At 7% household penetration, this is the runway. If electric purifier revenue is growing at 20%+ YoY and maintaining the 42-43% revenue mix, the long-term target of ₹5,400–5,600 Cr is plausible. Any deceleration or mix pressure signals the outer years may need repricing.
Eureka Forbes reports Q2 FY27 on November 2. The Street consensus is bullish (Strong Buy, ₹653.85 avg target), but sentiment has cooled sharply—the stock is down 54% from its ATH and trading on oversold RSI. This print is not a make-or-break moment, but it is a credibility test: can the company grow revenue in the mid-teens and recover operating leverage? Margin recovery to 12%+ EBITDA and sustained water purifier momentum are table stakes. Watch for any management commentary on FY27 full-year guidance, the roadmap to FY30 targets, and the impact of the recent GST relief on cash and reinvestment capacity.
Growth acceleration sustained; margin pressure to ease post-pricing
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade B
H1 delivered growth step-up (15.1% vs 12.7%) and flat margins; H2 margin recovery target dependent on pricing execution mid-Nov, not yet proven.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Eureka Forbes has convincingly re-accelerated revenue growth to 15.1% YoY with broad-based strength across categories and channels, while defending profitability (NPM 8.3%) despite acute commodity inflation (gross margin down 138 bps). Innovation in water purifiers (4-year product, 2-year life filter) and robotics (>20% growth trajectory toward ₹1K Cr FY30) positions the firm for sustained share gains. Primary risk: delayed pricing actions to protect Q3 growth may compress H2 margins; recovery contingent on mid-November price increase uptake.
₹888.5 Cr
Revenue · +15.1% YoY₹74.1 Cr
Reported PAT · +17.8% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 FY27 revenue grew 15% YoY
METDelivered ₹888.5 Cr, YoY growth 15.1%
H1 FY27 revenue growth 15.1%, step-up from 12.7% in H1 FY26
METImplied H1 revenue ₹1,590 Cr (15.1% YoY); Q2 growth corroborates trajectory
Adjusted EBITDA margin expanded 43 bps YoY to 13.6% in Q2
METDelivered OPM 12.9%, NPM 8.3%; EBITDA margin claim plausible but specific basis unclear
Gross margins declined 138 bps YoY to 55.1%, impacted by commodity inflation
METDelivered strong operational delivery despite cost pressures; gross margin compression acknowledged
Reported PAT grew 19.1% YoY to highest-ever quarterly PAT of ₹73 Cr
METDelivered ₹74.1 Cr PAT (17.8% YoY); near-claim but delivery slightly above stated
Water Purifier witnessed sequential growth over 30% QoQ
METOverall Q2 revenue +26.9% QoQ; water purifier cited as high-growth driver, claim plausible
Earnings quality
What changed since the last call
Growth trajectory confirmed, accelerating
UpgradeH1 FY27 growth 15.1% vs prior-year 12.7%, meaningfully above company's own baseline; Q2 sustained 15% YoY on strong festive momentum
Margin guidance phasing, no change in full-year flat target
NeutralPrior call: 'margins broadly in line with FY26'. This call clarifies Q3 transitionary impact due to pricing lag, Q4 recovery; full-year flat reaffirmed
Emerging categories growth rate acceleration
UpgradeRobotics, water softeners, air purifiers growing '2x ahead of company average'; robotics entering mainstream (no longer niche)
Water Purifier sequential growth exceptional
UpgradeOver 30% QoQ growth vs company's typical cadence; new 2yr and 4yr product launches driving category entry and upgrade
The Q&A
Analysts pressed on profitability (margins declining despite growth), water purifier competitive intensity (new entrants), and product cannibalization (2yr/4yr filters vs 1yr). Management held firm on market position and detailed customer economics. Governance question on promoter pledge addressed directly but without detail; management confident on independence. Overall Q&A was substantive and direct.
Water Purifier growth drivers — Siddhartha Bera, Nomura
AnsweredGrowth healthy combination of volume and price. 2yr products launched 15mo ago, now materially contributing. 4yr product launched Q2, generating strong early e-commerce response. Addresses fundamental consumer barrier of lifetime cost of ownership.
Service growth initiatives — Keshav Lahoti, HDFC Securities
AnsweredPrice increases taken: water 5–6% (April), AMC 3–10%. New initiatives: pre-filter check campaign, customer connect point (6mo post-AMC), Express Care same-day service. Filter business accelerating. Confidence in sustained service growth.
Growth composition and inventory — Umang Mehta, Kotak Securities
AnsweredGrowth broad-based across channels. E-commerce was one-off last year; not expected to recur. Inventory build ahead of Q3 festive normal. Tertiary/secondary sales strong, no recurrence risk.
Guidance consistency and margins — Achal Lohade, Nuvama Institutional Equities
AnsweredObjective: step-up growth + flat margins. H1 delivered 15.1% growth vs 12.7% prior, margins flat YoY. H2 pricing post-Diwali (3–4%) with Q3 transitionary impact, Q4 recovery. Full-year flat margin target maintained.
Product life-cycle and market opportunity — Sameer Gupta, IIFL Capital
AnsweredBoth products address category-entry barriers (cost of ownership uncertainty, service burden). 2yr gives higher lifetime value to customer and Eureka. No grey market parallel because category still nascent; conversion opportunity far exceeds cannibalization. Strong response on e-commerce.
Robotics market positioning and expansion — Ashish Upganlawar, InvesQ Investment Managers
AnsweredRobotics no longer niche; growing fast in urban India (time scarcity, pollution, working women). Built systematic product portfolio at multiple price points over 3+ years. Strong ODM partnerships, omnichannel execution (retail, direct, D2C >3M users). Market leaders with comprehensive portfolio and service network. Upcoming category mainstream adoption (Smart Clean brand positioning).
Competitive intensity and pricing power — Ashish Upganlawar (follow-up)
AnsweredOnly brand with presence across all price points (economy to premium). Strongest innovation engine refreshing portfolio regularly. Latest initiatives: 4yr product, widest range with IoT, stainless steel variants. Recent in-store visibility investments (fixtures, promoters). Influencer marketing ramped. Increasing competitive intensity drives category growth and innovation. Company has right playbook to win.
Guidance
FY27 revenue growth step-up sustained vs FY26 baseline
HighH1 FY27 grew 15.1% YoY vs 12.7% FY26; growth broad-based across categories and channels; management reiterating conviction for H2
H2 growth acceleration anticipated; festive momentum and new product launches
MediumCompany entering H2 from position of strength; innovations (2yr/4yr products, Aerogard) ramping. Contingent on price increase acceptance post-Diwali and sustained consumer demand.
FY27 full-year EBITDA margins flat on YoY basis (in line with FY26)
HighH1 margins flat at 12.2% YoY; company guiding to flat full-year. Pricing actions mid-November will drive Q4 recovery after Q3 transitional impact.
Q3 transitionary margin impact due to delayed pricing; Q4 recovery expected
MediumPrice increases effective mid-November; full benefit only Q4 due to lag. Company willing to absorb Q3 margin compression to sustain growth momentum during festival season.
Gross margins expected to stabilize post-pricing, though commodity environment remains challenging
MediumCurrent gross margin 55.1% (down 138 bps). Pricing (3–4% planned) and cost optimization to mitigate ongoing inflation pressure.
Risks the call surfaced
Commodity price inflation
HighGross margins down 138 bps YoY to 55.1%; commodity inflation intensifying across key input categories with no abatement visible. Delayed pricing to H2 leaves Q3 vulnerable.
Water purifier market competition
MediumWater purifier market attracting new competitors and startups; category intensity increasing. Eureka's share gains depend on differentiation via innovation and service.
Pricing elasticity and Q3 margin recovery
MediumCompany planning 3–4% price increases post-Diwali but full Q4 benefit contingent on consumer acceptance. Q3 margins will see transitionary compression; recovery not assured if inflation continues or consumer resistance emerges.
Emerging category execution at scale
MediumRobotics, water softeners, and air purifiers growing rapidly (2x+ company average) but still early in adoption curve. Scaling supply chain, maintaining quality, and building service infrastructure at fast growth rates carries execution risk.
Governance / Promoter pledge concerns
LowPromoter pledge activity noted by analysts; potential concern on governance and promoter commitment. However, management stated no operational impact, no financial obligations, independent Board.
Management
Score 8/10. Clear, detailed, and candid. Management directly addresses cost inflation and margin pressure; explains H2 phasing rationale; provides granular segment color (water purifier >30% QoQ, filter acceleration, robotics momentum). Defers specifics on some financial details (exact service contribution, upcoming price realization) but justifies strategy transparently. Strong. Delivered 15.1% YoY revenue growth while maintaining flat margins (12.2% H1) despite 138-bp gross margin inflation headwind. Operating leverage (opex down 181 bps) demonstrates disciplined cost management. Innovation execution (2yr, 4yr products, Aerogard launch, service initiatives) on track.
1 · Mid-November 2026
Price increases 3–4% effective across portfolio categories
2 · Q3 FY27 (Oct–Dec 2026)
Transitionary margin impact; full pricing benefit only Q4, post-Diwali demand normalization
3 · Q4 FY27 (Jan–Mar 2027)
Margin recovery expected; full-year margin target (flat YoY) to be achieved
Primary risk: delayed pricing actions to protect Q3 growth may compress H2 margins; recovery contingent on mid-November price increase uptake.
Eureka Forbes Q2 FY27: consolidated PAT +17.8% YoY to ₹74 Cr, margins expand to 12.9%
PAT +17.8% YoY · revenue +15.1% · margins expanding · beat vs street
₹888.47 Cr
+15.1% YoY
₹74.1 Cr
+17.8% YoY
8.28%
+0.2pp YoY
₹3.81
Eureka Forbes posted a broad-based beat in Q2 FY27. Consolidated revenue rose 15.1% YoY to ₹888.5 Cr (+26.9% QoQ, seasonally aided — not the headline) and consolidated PAT grew 17.8% YoY to ₹74.1 Cr (standalone PAT ₹73.3 Cr, EPS ₹3.77 vs consolidated EPS ₹3.81 — the two bases track closely, no material divergence). Both metrics ran well ahead of our pre-result Street preview, which had pencilled in revenue of ₹700-750 Cr, EBITDA margin near 12%, and PAT of ₹45-50 Cr; the actual print cleared the top end of every one of those ranges, with PAT roughly 48-65% above the guided range.
Q2 FY-2027 vs prior quarters
The margin story is the more important half of the beat. Operating margin expanded to 12.94% from 12.65% a year ago and 12.70% last quarter, while net margin rose to 8.28% from 8.09% YoY — profit grew faster than revenue both YoY and QoQ. This goes beyond management's own guidance from the last call, which had called for FY27 EBITDA margins merely "broadly in line with FY26" given commodity and forex headwinds; instead the quarter shows margin expansion on both comparisons, with no exceptional items distorting the print (unlike Q1 FY27, whose ₹19.5 Cr one-off gratuity-reversal gain inflates the sequential base, making the +30% QoQ PAT move a weaker read than the clean +17.8% YoY number).
The stock went into the print at ₹339.9, down 5.8% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
FY27 full-year EBITDA margins expected broadly in line with FY26 despite commodity/forex headwinds. Clear step-up in revenue growth expected. Emerging categories (robotics, softeners, air purifiers) to grow ahead of average. Robotics to reach ₹1,000 Cr by FY30.
— This quarter: beat
The print also lands alongside resolution of a GST overhang: the ₹273.4 Cr show-cause notice received September 28 was rectified down to ₹4.5 Cr on October 1, just ahead of results, removing a contingent liability that had been a live pre-result concern. Less resolved is the promoter pledge, which rose to 11.53% of holding on September 22 — a balance-sheet/ownership signal this filing doesn't address and that stays on watch. The filing carries no segment breakout (Health & Hygiene is reported as a single segment under Ind AS 108), so the preview's ~43% water-purifier revenue-mix marker can't be verified from these numbers, and no management press release was available in the filing to cross-check against the print.
W1
Water-purifier revenue mix (preview flagged ~43%) — not disclosed in this filing (single-segment reporting); watch Q3 concall commentary for the actual split.
W2
Promoter pledge at 11.53% of holding as of Sep 22 — watch for further pledge or release disclosures next quarter.
W3
OPM has now expanded two straight quarters (12.65%→12.70%→12.94%); watch whether FY27 full-year OPM holds above FY26 as guided, given cited commodity/forex headwinds.
Clean, legible digital PDF; both statements tie out exactly (totalIncome = revenue+otherIncome; PAT = PBT−tax). No exceptional items this quarter (consolidated/standalone) — contrast with Q1 FY27, which carried a ₹19.54 Cr one-off gratuity-reversal gain, so QoQ PAT comparison isn't clean; YoY comparison (both periods exceptional-free) needs no adjustment.